Expanded Access Program of AMTAGVI that is Out of Specification for Commercial Release
Categories (click each to see list of all clinical trials associated with that category): CRC Coordinated Studies (ONC), Cellular Therapy Support Service - Other CAR (ONC), Melanoma (ONC)
Current Status: Open
Phase: N/A (Cancer Control)
Principal Investigator: Marr, Alissa
Contact Information:
Sarah Snook
sarah.snook@unmc.edu
Summary
Primary Objective: To provide access to OOS AMTAGVI
Safety Objective: To assess safety of OOS AMTAGVI (Grade 3 and higher Adverse Events ([AEs]; and Serious Adverse Events [SAEs])
Efficacy Objective: To assess efficacy of OOS AMTAGVI using response rate as assessed by investigator, and as measured by Overall Survival (OS)